FINWIRES · TerminalLIVE
FINWIRES

Cosmos Health Unit Enters 5-Year Contract Manufacturing Deal With Viofar Over Cardiovascular Medicine

By

Cosmos Health (COSM) said Friday its unit Cana Laboratories entered a new five-year contract manufacturing deal with Viofar to secure 2.5 million additional units of the Rosartia cardiovascular medicine.

Under the five-year deal, Cana will manufacture 500,000 units of the medicine annually, across the 5mg, 10mg, 20mg and 40mg dosages.

The new agreement ramps Cana's cumulative contract manufacturing orderbook to over 27.5 million units, and provides greater visibility into future production volumes and related cash flows, the company said.

Price: $0.27, Change: $+0.02, Percent Change: +6.36%

What else is happening in Wire?

Wire

National Beverage Fiscal Q1 Earnings Fall, Revenue Rises

National Beverage (FIZZ) reported fiscal Q1 earnings late Thursday of $0.50 per diluted share, down from $0.60 a year earlier.One analyst polled by FactSet expected $0.59.Revenue in the three months ended Aug. 1 rose to $330.7 million from $330.5 million a year earlier.One analyst projected $342.1 million.National Beverage shares fell 3% in after-hours trading.

$FIZZ
Wire

Zumiez Q2 Loss Widens, Revenue Falls; Sets Q3 Guidance

Zumiez (ZUMZ) reported Thursday Q2 loss of $0.17 per diluted share, compared with loss of $0.06 a year earlier.Two analysts surveyed by FactSet expected a loss of $0.14.Revenue for the quarter ended Aug. 1 was $209.0 million, down from $214.3 million a year ago.Two analysts expected $212.1 million.The company expects Q3 EPS of $0.00 to $0.10 on revenue of $222 million to $226 million. Two analysts expect EPS of $0.59, if comparable, and revenue of $238 million.Shares of the company fell over 15% in after-hours trading.

$ZUMZ
Wire

Box, OpenAI Launch Integration to Access Enterprise Content in ChatGPT

Box (BOX) entered a collaboration with OpenAI to launch an integration that lets users access and work with business content stored in its platform directly from ChatGPT.The integration can help accelerate clinical research, streamline legal workflows, and support financial analysts reviewing company reports, Box said Thursday in a statement.The feature is available starting Thursday for Box customers, with OpenAI rolling out access to users of ChatGPT's paid tiers over the coming days.Price: $34.10, Change: $-0.39, Percent Change: -1.13%

$BOX